Showing results (141-150 of 156) with videos related to

Sort By:
Pageof 16
Hepatic Oncology|September 8, 2018
Regorafenib and the RESORCE trial: a new second-line option for hepatocellular carcinoma patientsJordi Bruix
Hepatic Oncology|September 8, 2018
RFA plus lyso-thermosensitive liposomal doxorubicin: in search of the optimal approach to cure intermediate-size hepatocellular carcinomaRiccardo Lencioni, Dania Cioni
Hepatic Oncology|September 8, 2018
Dysregulated fatty acid metabolism in hepatocellular carcinomaMingda Wang, Jun Han, Hao Xing, et al.
Hepatic Oncology|September 8, 2018
'Hug sign': a new radiological sign of intraprocedural success after combined treatment for hepatocellular carcinomaRoberto Iezzi, Maurizio Pompili, Eleonora Brigida Annicchiarico, et al.
Hepatic Oncology|September 8, 2018
Radiologic criteria of response to systemic treatments for hepatocellular carcinomaFrancesco Tovoli, Matteo Renzulli, Alessandro Granito, et al.
Hepatic Oncology|September 8, 2018
Corrigendum
Hepatic Oncology|October 11, 2018
Molecular classification of hepatocellular adenomas: impact on clinical practiceAnne-Laure Védie, Olivier Sutter, Marianne Ziol, et al.
Hepatic Oncology|October 11, 2018
How Rap and its GEFs control liver physiology and cancer development. C3G alterations in human hepatocarcinomaCelia Sequera, Sara Manzano, Carmen Guerrero, et al.
Hepatic Oncology|July 12, 2019
Transcatheter arterial chemoembolization combined with radiofrequency or microwave ablation for hepatocellular carcinoma: a reviewNikolaos Galanakis, Elias Kehagias, Nikolas Matthaiou, et al.
Hepatic Oncology|August 11, 2020
Long-lasting remission in a metastatic hepatocellular carcinoma patient after combined regorafenib therapy and surgeryElisabetta Goio, Luca Ielasi, Francesca Benevento, et al.
Pageof 16